Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

RNA Editing of Tumor Suppressor Mir-26a Promotes Malignant Progenitor Propagation in Chronic Myeloid Leukemia

Raymond H Diep, Qingfei Jiang, PhD, Jane Isquith, MS, Maria A. Zipeto, PhD, Jessica Pham, Nathan Delos Santos, BS, Julisia Chau, B.S., Sheldon Morris, MD MPH, Catriona Jamieson, MD PhD

Blood (2018) 132 (Supplement 1): 2611.

https://doi.org/10.1182/blood-2018-99-116988

Published: 2018

Journal Articles

Genetic Modulation of Adenosine-to-Inosine RNA Editing Selectively Disrupts Inflammasome and Extracellular Matrix Genes in Multiple Myeloma

Leslie A Crews, PhD, Phoebe Mondala, BS, Elisa Lazzari, PhD, Gabriel Pineda, PhD, Christina Wu, PhD, Caitlin L. Costello, MD, Catriona Jamieson, MD PhD

Blood (2018) 132 (Supplement 1): 1324.

https://doi.org/10.1182/blood-2018-99-120326

Published: 2018

Journal Articles

Adar-Mediated Aberrant a-to-I RNA Editing Is Driven By 1q Amplification and Contributes to Proteasome Inhibitor Resistance in Multiple Myeloma

Alessandro Lagana, PhD, Violetta Leshchenko, PhD, David Melnekoff, BS, MSc, Itai Beno, PhD, Deepak Perumal, PhD, Jonathan Keats, PhD, Mary DeRome, MS, Jennifer Yesil, MS, Daniel Auclair, PhD, Deepu Madduri, MD, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2017) 130 (Supplement 1): 268.

https://doi.org/10.1182/blood.V130.Suppl_1.268.268

Published: 2017

Journal Articles

RNA Editing By APOBEC3A Confers Dynamic Mutational Load in Monocytic Leukemias

Bora E Baysal, MD PhD, Shraddha Sharma, PhD, Jianmin Wang, PhD, Eduardo Cortes-Gomez, M.S, Scott Portwood, MS, Eunice S. Wang, MD

Blood (2017) 130 (Supplement 1): 3939.

https://doi.org/10.1182/blood.V130.Suppl_1.3939.3939

Published: 2017

Journal Articles

Transcript Expression, Intron Retention, and RNA Editing Are Conserved in Human Platelets over a 4 Year Period

Jesse W Rowley, PhD, Robert A. Campbell, PhD, Hansjorg Schwertz, MD, Andrew S. Weyrich, PhD, Neal D Tolley, Deepak Voora, MD, Matthew T. Rondina, MD

Blood (2017) 130 (Supplement 1): 456.

https://doi.org/10.1182/blood.V130.Suppl_1.456.456

Published: 2017

Journal Articles

Decoding the RNA Editome of Normal Versus Malignant Progenitor Cell Aging Short Title: RNA Editing in Normal Aging and MDS/AML Stem Cells

Leslie A Crews, PhD, Qingfei Jiang, PhD, Larisa Balaian, PhD, Heather Leu, BS, Nathan Delos Santos, Angela C Court, Anil Sadarangani, PhD, Sheldon Morris, MD, Rainer F. Storb, MD, Anna Kulidjian, MD, Edward D. Ball, MD, Catriona Jamieson, MD PhD

Blood (2016) 128 (22): 1519.

https://doi.org/10.1182/blood.V128.22.1519.1519

Published: 2016

Journal Articles

Aberrant a-to-I RNA Editing and Prognostic Impact of Adar in Multiple Myeloma Patients with 1q Amplification

Alessandro Lagana, PhD, Deepak Perumal, PhD, Violetta V Leshchenko, PhD, Pei-Yu Kuo, MS, Brian Kidd, PhD, Jonathan J Keats, PhD, Mary Derome, MS, Jennifer Yesil, MS, Daniel Auclair, PhD, Deepu Madduri, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2016) 128 (22): 357.

https://doi.org/10.1182/blood.V128.22.357.357

Published: 2016

Journal Articles

The Anti-HIV-1 Cytidine Deaminase APOBEC3G Is a Cellular Site-Specific RNA Editing Enzyme

Bora E. Baysal, MD PhD, Santosh Patnaik, MD PhD, Robert T Taggart, PhD, Shraddha Sharma, PhD

Blood (2016) 128 (22): 547.

https://doi.org/10.1182/blood.V128.22.547.547

Published: 2016

Journal Articles

Prevalence of RNA Editing Events Affecting Coding Regions in Pediatric Leukemia

Ji Wen, PhD, Michael Rusch, Michael Edmonson, PhD, Charles Mullighan, MBBS, MSc, MD, Tanja A. Gruber, MD PhD, David W Ellison, MD, Jinghui Zhang, PhD

Blood (2016) 128 (22): 3928.

https://doi.org/10.1182/blood.V128.22.3928.3928

Published: 2016

Journal Articles

RNA Editing Enzyme ADAR1 Accelerates Normal Hematopoiesis Cell Cycle By Regulating microRNA Biogenesis

Qingfei Jiang, PhD, Maria A. Zipeto, PhD, Nathaniel Delos Santos, BS, Heather Leu, BS, Jane Isquith, MS, Etienne Atien, BS, Catriona Jamieson, MD PhD

Blood (2016) 128 (22): 887.

https://doi.org/10.1182/blood.V128.22.887.887

Published: 2016

Journal Articles

Tracking Human Myeloma Cell Therapeutic Resistance Using a Novel Diagnostic Assay for Detection of RNA Editing Biomarkers of Cancer Stem Cell Generation

Elisa Lazzari, MS, Leslie A Crews, PhD, Maria Anna Zipeto, PhD, Shawn Ali, BA, Catriona HM Jamieson, MD PhD

Blood (2014) 124 (21): 3406.

https://doi.org/10.1182/blood.V124.21.3406.3406

Published: 2014

Journal Articles

A-To-I RNA Editing By ADAR1 Is Essential For Hematopoiesis

Brian Liddicoat, Robert Piskol, Alistair Chalk, Miyoko Higuchi, Peter Seeburg, Jin Billy Li, Jochen Hartner, Carl R Walkley, PhD, BPharm

Blood (2013) 122 (21): 1199.

https://doi.org/10.1182/blood.V122.21.1199.1199

Published: 2013

Journal Articles

ADAR1 Is Essential For Erythroid Development

Brian Liddicoat, Jochen Hartner, Alistair Chalk, Jun Lu, PhD, Stuart H. Orkin, MD, Carl R Walkley, PhD, BPharm

Blood (2013) 122 (21): 9.

https://doi.org/10.1182/blood.V122.21.9.9

Published: 2013

Journal Articles

An Essential Role of the RNA Editing Enzyme ADAR1 in T Cell Development.

Richard XuFeng, MD, Qiong Yang, PhD, Youzhong Yuan, MD, PhD, Binfeng Lu, PhD, Tao Cheng, MD, Qingde Wang, MD, PhD

Blood (2009) 114 (22): 917.

https://doi.org/10.1182/blood.V114.22.917.917

Published: 2009

Journal Articles

The RNA Editing Enzyme ADAR1 Is Required for Survival of Differentiating Hematopoietic Progenitor Cells in Adult Mice.

Feng Xu, MD, Qingde Wang, MD., PhD., Hongmei Shen, PhD, Hui Yu, MD, PhD, Yanxin Li, PhD, Tao Cheng, MD

Blood (2008) 112 (11): 1395.

https://doi.org/10.1182/blood.V112.11.1395.1395

Published: 2008

NARROW

RNA Editing of Tumor Suppressor Mir-26a Promotes Malignant Progenitor Propagation in Chronic Myeloid Leukemia

Genetic Modulation of Adenosine-to-Inosine RNA Editing Selectively Disrupts Inflammasome and Extracellular Matrix Genes in Multiple Myeloma

Adar-Mediated Aberrant a-to-I RNA Editing Is Driven By 1q Amplification and Contributes to Proteasome Inhibitor Resistance in Multiple Myeloma

RNA Editing By APOBEC3A Confers Dynamic Mutational Load in Monocytic Leukemias

Transcript Expression, Intron Retention, and RNA Editing Are Conserved in Human Platelets over a 4 Year Period

Decoding the RNA Editome of Normal Versus Malignant Progenitor Cell Aging Short Title: RNA Editing in Normal Aging and MDS/AML Stem Cells

Aberrant a-to-I RNA Editing and Prognostic Impact of Adar in Multiple Myeloma Patients with 1q Amplification

The Anti-HIV-1 Cytidine Deaminase APOBEC3G Is a Cellular Site-Specific RNA Editing Enzyme

Prevalence of RNA Editing Events Affecting Coding Regions in Pediatric Leukemia

RNA Editing Enzyme ADAR1 Accelerates Normal Hematopoiesis Cell Cycle By Regulating microRNA Biogenesis

Tracking Human Myeloma Cell Therapeutic Resistance Using a Novel Diagnostic Assay for Detection of RNA Editing Biomarkers of Cancer Stem Cell Generation

A-To-I RNA Editing By ADAR1 Is Essential For Hematopoiesis

ADAR1 Is Essential For Erythroid Development

An Essential Role of the RNA Editing Enzyme ADAR1 in T Cell Development.

The RNA Editing Enzyme ADAR1 Is Required for Survival of Differentiating Hematopoietic Progenitor Cells in Adult Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only